Osteoporosis Foundation of New Mexico Santa Fe Bone Symposium 2024

+ Include: 13 videos + 13 audios + 13 file sub vtt, size: 13.25 GB  : endocrinologists, rheumatologists, and primary care physicians + Information:

1. Overview

The Osteoporosis Foundation of New Mexico Santa Fe Bone Symposium 2024 provides a comprehensive clinical review of the latest advancements in the diagnosis, treatment, and management of osteoporosis and metabolic bone diseases. The program highlights emerging therapeutics, the effects of hormones on bone health, and practical strategies for optimizing bone health in complex patient populations.

Course Date: 2024

2. Learning Objectives

• Evaluate the efficacy and clinical application of new and emerging therapeutics for osteoporosis and rare bone diseases.

• Implement evidence-based strategies for managing patients discontinuing denosumab and treating osteoporosis in the very elderly.

• Assess the relationship between osteoporosis medications and cardiovascular diseases to ensure safe prescribing practices.

• Analyze the role of hormones, including estrogen and testosterone, in the management and prevention of bone loss.

• Formulate protocols for optimizing bone health prior to orthopedic surgery and effectively utilizing osteoanabolic agents.

3. Target Audience

Best for endocrinologists, rheumatologists, and primary care physicians who want updates on osteoporosis management and novel bone therapeutics.

4. Topics

Topics (13 Lectures):

1. 01 Oral Abstracts Presentations by Endocrinology Fellows

2. 02 Dr. Bobo Tanner, Winner of the Paul D. Miller Award

3. 03 Osteoporosis Treatment in the Very Old

4. 04 Osteoporosis Drugs and Cardiovascular Diseases

5. 05 Case Discussions

6. 06 Management of Patients Discontinuing Denosumab

7. 07 Open Microphone Panel Discussion

8. 08 Estrogen in the Management of Osteoporosis

9. 09 Effects of Testosterone on Bone – Its Role in the Management of Osteoporosis

10. 10 Treat-to-Target for Osteoporosis

11. 11 New and Emerging Therapeutics for Rare Bone Diseases

12. 12 Update on Clinical Aspects and Uses of Osteoanabolic Agents

13. 13 Bone Health Optimization for Orthopedic Surgery